Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Capricor Therapeutics (CAPR) Return on Assets (2016 - 2025)

Capricor Therapeutics has reported Return on Assets over the past 15 years, most recently at 0.42% for Q4 2025.

  • Quarterly results put Return on Assets at 0.42% for Q4 2025, down 12.0% from a year ago — trailing twelve months through Dec 2025 was 0.42% (down 12.0% YoY), and the annual figure for FY2025 was 0.4%, down 5.0%.
  • Return on Assets for Q4 2025 was 0.42% at Capricor Therapeutics, up from 0.63% in the prior quarter.
  • Over the last five years, Return on Assets for CAPR hit a ceiling of 0.31% in Q4 2024 and a floor of 0.7% in Q3 2023.
  • Median Return on Assets over the past 5 years was 0.48% (2023), compared with a mean of 0.49%.
  • Biggest five-year swings in Return on Assets: decreased -20bps in 2023 and later grew 18bps in 2024.
  • Capricor Therapeutics' Return on Assets stood at 0.49% in 2021, then dropped by -13bps to 0.56% in 2022, then rose by 17bps to 0.47% in 2023, then soared by 34bps to 0.31% in 2024, then plummeted by -38bps to 0.42% in 2025.
  • The last three reported values for Return on Assets were 0.42% (Q4 2025), 0.63% (Q3 2025), and 0.49% (Q2 2025) per Business Quant data.